Amedeo's Top 20

Amedeo Smart

Independent Medical Education

10 October 2016

Multidisciplinary Journal Club

  1. Tao W, Gill HS.
    M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection.
    Vaccine 2015.

  1. Costanzo MR, Ponikowski P, Javaheri S, Augostini R, et al.
    Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial.
    Lancet 2016;388:974-82.

  2. Kukol A, Hughes DJ.
    Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites.
    Virology 2014;454-:40-7.

  3. Singh D, Papi A, Corradi M, Pavlisova I, et al.
    Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
    Lancet 2016;388:963-73.

  4. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, et al.
    Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
    N Engl J Med 2016;375:1033-43.

  1. de Boer M, van den Berk G, van Holten N, Oryszczyn J, et al.
    Intolerance of dolutegravir containing cART regimens in real life clinical practice.
    AIDS 2016.

  2. Saver JL, Goyal M, van der Lugt A, Menon BK, et al.
    Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.
    JAMA 2016;316:1279-88.

  3. Hankey GJ.
    Lancet 2016.

  4. Litton E, Baker S, Erber WN, Farmer S, et al.
    Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.
    Intensive Care Med 2016.

  5. Silverman MG, Ference BA, Im K, Wiviott SD, et al.
    Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
    JAMA 2016;316:1289-97.

  1. Herranz E, Gianni C, Louapre C, Treaba CA, et al.
    The neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Ann Neurol 2016.

  2. Coles N, Birken C, Hamilton J.
    Emerging treatments for severe obesity in children and adolescents.
    BMJ 2016;354:i4116.

  3. Rusert P, Kouyos RD, Kadelka C, Ebner H, et al.
    Determinants of HIV-1 broadly neutralizing antibody induction.
    Nat Med 2016.

  4. Shukla R, Kramer J, Cao Y, Ying J, et al.
    Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
    Am J Gastroenterol 2016.

  5. Sitruk-Ware R.
    Hormonal contraception and thrombosis.
    Fertil Steril 2016.

  1. Williams MT, Yousafzai YM, Elder A, Rehe K, et al.
    The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
    Blood 2016;127:1998-2006.

  2. Kulkarni VV, Dutta S, Sundaram V, Saini SS, et al.
    Preterm Thrombocytopenia and Delay of Ductus Arteriosus Closure.
    Pediatrics 2016.

  3. Montaniel KR, Harrison DG.
    Is Hypertension a Bone Marrow Disease?
    Circulation 2016.

  4. Rieben C, Segna D, da Costa BR, Collet TH, et al.
    Subclinical Thyroid Dysfunction and the Risk of Cognitive Decline: a Meta-Analysis of Prospective Cohort Studies.
    J Clin Endocrinol Metab 2016.

  5. Tsuda K, Yamamoto K, Leppold C, Tanimoto T, et al.
    Trends of media coverage on human papillomavirus vaccination in Japanese newspapers.
    Clin Infect Dis 2016.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016